STOCK TITAN

DuPont de Nemours (DD) Financials

DD NYSE
Trailing 12 months to September 30, 2026
Revenue $7.1B +3.2% YoY
Net Income $301.0M n/m YoY
EPS (Diluted) -$1.86 FY2025 annual
Free Cash Flow $793.0M YoY not available
Market Cap $19.8B as of Nov 19, 2026
Price / Sales 2.8x on $7.1B revenue, trailing 12 months to September 30, 2026
Price / Earnings 65.9x on $301.0M net income, trailing 12 months to September 30, 2026
Price / Book 1.5x on $13.6B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DD SEC filings page.

DuPont de Nemours, Inc. (DD) reported $7.1B in revenue over the twelve months to Sep 30, 2026, up 3.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DD FY2025

Revenue is steady and gross margins improved, but 2025 produced a net loss despite positive, weakening cash generation.

From FY2023 to FY2025, revenue rose 3.6% while gross profit rose 8.8%. Yet net income shifted from a $423M profit to a $779M loss, so the break occurs below gross profit, in reported items not separately supplied here.

The balance sheet contracted materially: assets fell 44.0% and long-term debt fell 59.8% between FY2023 and FY2025. Liabilities as a share of assets moved from 35.9% to 34.6%, so the smaller balance sheet did not carry a higher relative liability burden.

Cash conversion weakened: operating cash flow fell from $845M in FY2023 to $560M in FY2025. Capital expenditures consumed 59.5% of FY2025 operating cash flow, leaving less cash after reinvestment even though operations remained cash-generative.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 50 / 100
Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of DuPont de Nemours, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
44

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. DuPont de Nemours, Inc. scores 44/100 on it among other operating companies.

Growth
37

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. DuPont de Nemours, Inc. scores 37/100 on it among other operating companies.

Leverage
70

DuPont de Nemours, Inc. carried $0.23 of long-term debt for every $1 of shareholders' equity at the end of fiscal year 2025, a debt-to-equity ratio of 0.23. With no EBITDA figure for fiscal year 2025, DuPont de Nemours, Inc. is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 70/100 among other operating companies measured the same way.

Liquidity
69

DuPont de Nemours, Inc. held $2.42 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 2.42. Liquidity ranks operating companies on that ratio, and DuPont de Nemours, Inc. scores 69/100 among other operating companies.

Cash Flow
48

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. DuPont de Nemours, Inc. scores 48/100 on it among other operating companies.

Returns
33

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. DuPont de Nemours, Inc. scores 33/100 on it among other operating companies.

Piotroski F-Score Neutral
6/9

DuPont de Nemours, Inc. passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

DuPont de Nemours, Inc. reported a net loss of $779.0M while generating $560.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.9B
YoY+4.1%
QoQ+2.7%
5Y CAGR-10.2%
10Y CAGR-17.3%

DuPont de Nemours, Inc. generated $1.9B in revenue in Q3 2026. This represents an increase of 4.1% from the same quarter a year earlier. Against the prior quarter it is up 2.7%.

Net Income
$123.0M
YoYn/m
QoQ-14.0%
5Y CAGR-20.7%
10Y CAGR-17.1%

DuPont de Nemours, Inc. reported $123.0M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 14.0%.

EPS (Diluted)
$0.91
QoQ-13.3%

DuPont de Nemours, Inc. earned $0.91 per diluted share (EPS) in Q3 2026. Against the prior quarter it is down 13.3%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$339.0M
YoY+36.7%
QoQ+4.6%

DuPont de Nemours, Inc. generated $339.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 36.7% from the same quarter a year earlier. Against the prior quarter it is up 4.6%.

Cash & Debt
$1.7B
YoY-15.5%
QoQ-5.1%
5Y CAGR-0.2%
10Y CAGR-13.5%

DuPont de Nemours, Inc. held $1.7B in cash against $3.1B in long-term debt as of Q3 2026.

Shares Outstanding
133M
QoQ-1.9%

DuPont de Nemours, Inc. had 133M shares outstanding in Q3 2026. Against the prior quarter it is down 1.9%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
35.7%
YoY+1.4pp
QoQ+0.6pp

DuPont de Nemours, Inc.'s gross margin was 35.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Net Margin
6.6%
YoY+13.4pp
QoQ-1.3pp
5Y change-5.6pp
10Y change+0.1pp

DuPont de Nemours, Inc.'s net profit margin was 6.6% in Q3 2026, showing the share of revenue converted to profit. This is up 13.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.

Return on Equity
0.9%
YoY+1.5pp
QoQ-0.1pp
5Y change-0.6pp
10Y change-1.9pp

DuPont de Nemours, Inc.'s quarterly ROE was 0.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending
$42.0M
YoY-19.2%
QoQ0.0%

DuPont de Nemours, Inc. invested $42.0M in research and development in Q3 2026. This represents a decrease of 19.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Expenditures
$71.0M
YoY-4.1%
QoQ-6.6%

DuPont de Nemours, Inc. invested $71.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 4.1% from the same quarter a year earlier. Against the prior quarter it is down 6.6%.

Share Buybacks

Not reported for Q3 2026.

DD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DD quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$1.9B+4.1%$1.8B+4.0%$1.7B+4.3%$1.7B+0.2%$1.8B+4.7%$1.7B+1.9%$1.6B+0.8%$1.7B-41.7%
Cost of Revenue$1.2B+1.9%$1.2B+3.2%$1.1B+0.9%$1.1B-3.6%$1.2B+4.0%$1.1B+1.1%$1.1B-2.6%$1.1B
Gross Profit$667.0M+8.3%$639.0M+5.4%$602.0M+10.9%$598.0M+8.1%$616.0M+6.2%$606.0M+3.4%$543.0M+8.4%$553.0M
R&D Expenses$42.0M-19.2%$42.0M-20.8%$47.0M-6.0%N/A$52.0M-59.1%$53.0M-60.4%$50.0M-60.0%N/A
SG&A Expenses$260.0M-0.4%$269.0M+2.7%$255.0M+9.0%N/A$261.0M-29.1%$262.0M-37.3%$234.0M-39.1%N/A
Interest Expense$40.0M-52.9%$41.0M-51.2%$40.0M-51.8%N/A$85.0M-2.3%$84.0M-15.2%$83.0M-13.5%N/A
Income Tax$108.0Mn/m$75.0M+38.9%$31.0M+82.4%N/A-$11.0M-111.1%$54.0M-55.0%$17.0M-79.8%N/A
Net Income$123.0Mn/m$143.0M+142.4%$161.0Mn/m-$126.0Mn/m-$123.0M-127.1%$59.0M-66.9%-$589.0M-413.3%-$117.0Mn/m
EPS (Basic)$0.92$1.05$0.39n/m-$0.30n/m-$0.88$0.42-$1.41-420.5%-$0.28
EPS (Diluted)$0.91$1.05$0.39n/m-$0.30n/m-$0.88$0.42-$1.40-418.2%-$0.28
Diluted Shares (Avg)135M137M413M-1.7%N/A140M140M420M-1.0%N/A

Not reported in any period shown, so not listed: Operating Income, EBITDA.

DD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DD quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'25FilingQ4'2410-K
Total Assets$20.8B-45.3%$21.1B-42.4%$21.4B-40.4%$21.6B-41.1%$38.0B+1.6%$36.6B0.0%$36.0B-4.6%$36.6B-5.0%
Current Assets$4.7B-52.7%$4.9B-29.1%$5.6B-12.7%$5.6B-73.2%$10.0B+55.6%$6.8B+11.1%$6.5B-8.5%$20.8B+176.5%
Cash & Equivalents$1.7B-15.5%$1.7B-5.3%$710.0M-59.7%$715.0M-60.1%$2.0B+18.8%$1.8B+22.2%$1.8B-8.9%$1.8B-25.1%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$1.2B-32.7%$1.2B-47.3%$1.2B-46.1%$1.2B+3.7%$1.8B-17.8%$2.3B+6.1%$2.2B+3.1%$1.1B-47.4%
Accounts ReceivableN/AN/AN/A$910.0M+15.3%N/AN/AN/A$789.0M-47.9%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$7.8B-51.6%$7.8B-51.7%$7.9B-50.7%$7.9B+4.7%$16.2B-3.8%$16.2B-1.9%$15.9B-4.0%$7.6B-1.3%
Total Liabilities$7.1B-51.6%$7.2B-45.0%$7.2B-43.3%$7.5B-41.8%$14.7B+14.8%$13.0B+2.0%$12.7B-7.2%$12.8B-7.1%
Current Liabilities$2.0B-59.8%$2.0B-58.8%$2.1B-54.6%$2.3B-58.1%$5.0B+77.2%$4.9B+74.2%$4.6B+52.8%$5.5B+77.4%
Non-Current Liabilities$5.1B-47.4%$5.2B-36.8%$5.1B-36.8%$5.2B-29.7%$9.7B-2.8%$8.2B-18.1%$8.1B-24.3%$7.3B-31.5%
Long-Term Debt$3.1B-56.1%$3.1B-41.3%$3.1B-41.2%$3.1B-41.1%$7.0B-1.7%$5.3B-25.7%$5.3B-31.5%$5.3B-31.8%
Total Equity$13.6B-40.7%$13.8B-40.3%$14.0B-38.5%$13.9B-40.4%$22.9B-5.4%$23.1B-1.2%$22.8B-3.2%$23.4B-3.8%
Retained Earnings-$24.5Bn/m-$24.3Bn/m-$24.2Bn/m-$24.3Bn/m-$23.7Bn/m-$23.6Bn/m-$23.7Bn/m-$23.1Bn/m

DD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DD quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$410.0M+27.3%$400.0M+440.5%$232.0M+201.3%$87.0Mn/m$322.0M-35.2%$74.0M-86.0%$77.0M-84.4%-$752.0M-216.4%
Depreciation & Amortization$155.0M-4.3%$154.0M-7.2%$155.0M-3.1%$159.0M$162.0M-39.3%$166.0M-44.3%$160.0M-45.0%N/A
Stock-Based Compensation$15.0M+114.3%$14.0M-6.7%$13.0M+85.7%N/A$7.0M-58.8%$15.0M-25.0%$7.0M-69.6%N/A
Capital Expenditures$71.0M-4.1%$76.0M+52.0%$102.0M-16.4%$87.0M$74.0M+10.4%$50.0M-51.0%$122.0M-41.1%N/A
Free Cash Flow$339.0M+36.7%$324.0M+1250.0%$130.0Mn/m$0$248.0M-42.3%$24.0M-94.4%-$45.0M-115.7%N/A
Investing Cash FlowN/AN/AN/AN/AN/A-$111.0Mn/m-$247.0Mn/mN/A
Financing Cash FlowN/AN/AN/AN/AN/A-$184.0Mn/m-$206.0Mn/mN/A
Dividends Paid$80.0M-53.5%$81.0M-52.6%$82.0M-52.3%$82.0M-48.4%$172.0M+8.2%$171.0M+8.2%$172.0M+8.2%$159.0M+1.9%

Not reported in any period shown, so not listed: Share Buybacks.

DD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DD quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin35.7%+1.4pp35.1%+0.5pp35.8%+2.1pp35.3%+2.6pp34.3%+0.5pp34.6%+0.5pp33.7%+2.3pp32.7%
Net Margin6.6%+13.4pp7.9%+4.5pp9.6%+46.1pp-7.4%-0.5pp-6.9%-33.3pp3.4%-7.0pp-36.5%-48.3pp-6.9%-6.2pp
Return on Equity0.9%+1.5pp1.0%+0.8pp1.1%+3.7pp-0.9%-0.4pp-0.5%-2.4pp0.3%-0.5pp-2.6%-3.4pp-0.5%-0.4pp
Return on Assets0.6%+0.9pp0.7%+0.5pp0.8%+2.4pp-0.6%-0.3pp-0.3%-1.5pp0.2%-0.3pp-1.6%-2.1pp-0.3%-0.3pp
Current Ratio2.36+0.4x2.43+1.0x2.68+1.3x2.42-1.4x2.00-0.3x1.41-0.8x1.40-0.9x3.78+1.4x
Debt-to-Equity0.23-0.1x0.230.0x0.220.0x0.230.0x0.310.0x0.23-0.1x0.23-0.1x0.23-0.1x
Liabilities-to-Equity0.52-0.1x0.520.0x0.510.0x0.540.0x0.64+0.1x0.570.0x0.560.0x0.550.0x
Asset Turnover0.090.0x0.090.0x0.080.0x0.080.0x0.050.0x0.050.0x0.040.0x0.050.0x
FCF Margin18.1%+4.3pp17.8%+16.4pp7.7%+10.5pp0.0%13.8%-11.3pp1.4%-23.4pp-2.8%-20.7ppN/A

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
DuPont de Nemours, Inc. DD FY2025 $6.8B -$779.0M -11.4% $19.8B 50/100
LyondellBasell Industries N.V. LYB FY2025 $30.2B -$738.0M -2.5% $18.8B 34/100
International Flavors & Fragrances Inc. IFF FY2025 $10.9B -$361.0M -3.3% $19.7B 27/100
PPG Industries, Inc. PPG FY2025 $15.9B $1.6B 9.9% $26.3B 55/100
Sociedad Quimica y Minera de Chile SA SQM FY2025 $4.6B $588.1M 12.8% $13.7B 51/100
RPM International, Inc. RPM FY2026 $7.9B $661.4M 8.4% $13.2B 61/100

Frequently Asked Questions

DuPont de Nemours, Inc. (DD) reported $6.8B in total revenue for fiscal year 2025. This represents a 1.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

DuPont de Nemours, Inc. (DD) revenue grew by 1.9% year-over-year, from $6.7B to $6.8B in fiscal year 2025.

Yes, DuPont de Nemours, Inc. (DD) reported a net income of $301.0M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $779.0M, with a net profit margin of -11.4%.

DuPont de Nemours, Inc. (DD) reported diluted earnings per share of -$1.86 for fiscal year 2025. This represents a -210.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, DuPont de Nemours, Inc. (DD) had $715.0M in cash and equivalents against $3.1B in long-term debt.

DuPont de Nemours, Inc. (DD) had a gross margin of 34.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

DuPont de Nemours, Inc. (DD) had a net profit margin of -11.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, DuPont de Nemours, Inc. (DD) paid $1.43 per share in dividends during fiscal year 2025.

DuPont de Nemours, Inc. (DD) has a return on equity of -5.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

DuPont de Nemours, Inc. (DD) generated $227.0M in free cash flow during fiscal year 2025. This represents a -52.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

DuPont de Nemours, Inc. (DD) generated $560.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

DuPont de Nemours, Inc. (DD) had $21.6B in total assets as of fiscal year 2025, including both current and long-term assets.

DuPont de Nemours, Inc. (DD) invested $333.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

DuPont de Nemours, Inc. (DD) invested $193.0M in research and development during fiscal year 2025.

DuPont de Nemours, Inc. (DD) had 409M shares outstanding as of fiscal year 2025.

DuPont de Nemours, Inc. (DD) had a current ratio of 2.42 as of fiscal year 2025, which is generally considered healthy.

DuPont de Nemours, Inc. (DD) had a debt-to-equity ratio of 0.23 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

DuPont de Nemours, Inc. (DD) had a liabilities-to-equity ratio of 0.54 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

DuPont de Nemours, Inc. (DD) had a return on assets of -3.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

DuPont de Nemours, Inc. (DD) trades at 65.9x earnings, its market capitalization divided by $301.0M net income, trailing 12 months to September 30, 2026. The market capitalization is $19.8B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

DuPont de Nemours, Inc. (DD) trades at 2.8x sales, its market capitalization divided by $7.1B revenue, trailing 12 months to September 30, 2026. The market capitalization is $19.8B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

DuPont de Nemours, Inc. (DD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

DuPont de Nemours, Inc. (DD) reported a net loss of $779.0M while generating $560.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

DuPont de Nemours, Inc. (DD) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top